Immunogenicity of measles-rubella vaccine administered under India's Universal Immunization Programme in the context of measles-rubella elimination goal: A longitudinal study

CONCLUSIONS: MR vaccine administered below one year of age under the UIP resulted in seroprotection against rubella and measles in a large majority of children. Furthermore, its second dose resulted in seroprotection of all children. The current MR vaccination strategy of two doses, out of which the first is to be given to infants below one year of age, appears robust and justifiable among Indian children.PMID:37102515 | DOI:10.4103/ijmr.IJMR_4113_20

Source: Indian J Med Res - April 27, 2023 Category: Research Authors: Santosh Kumar Verma Dheeraj Shah Aaradhana Singh Praveen Kumar Singh Shukla Das Piyush Gupta Source Type: research